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Distal enhancers commonly contact target pro-
moters via chromatin looping. In erythroid cells, the
locus control region (LCR) contacts b-type globin
genes in a developmental stage-specific manner
to stimulate transcription. Previously, we induced
LCR-promoter looping by tethering the self-associa-
tion domain (SA) of Ldb1 to the b-globin promoter via
artificial zinc fingers. Here, we show that targeting
the SA to a developmentally silenced embryonic
globin gene in adult murine erythroblasts triggers
its transcriptional reactivation. This activity depends
on the LCR, consistent with an LCR-promoter loop-
ing mechanism. Strikingly, targeting the SA to the
fetal g-globin promoter in primary adult human eryth-
roblasts increases g-globin promoter-LCR contacts,
stimulating transcription to approximately 85% of
total b-globin synthesis, with a reciprocal reduction
in adult b-globin expression. Our findings demon-
strate that forced chromatin looping can override a
stringent developmental gene expression program
and suggest a novel approach to control the
balance of globin gene transcription for therapeutic
applications.INTRODUCTION
Long-range enhancers physically contact their target promoters
to form chromatin loops. The b-globin locus has been at the fore-
front of studies on the dynamics and mechanisms of chromatin
looping and gene regulation. In erythroid cells, a powerful distalenhancer called the locus control region (LCR), composed of
multiple DNase I hypersensitive sites (HSs), is in physical prox-
imity to the b-globin genes in a developmentally dynamicmanner
(Carter et al., 2002; Tolhuis et al., 2002). In primitive murine
erythroid cells, the LCR loops to the embryonic-type b-globin
gene promoters (εy and bh1), whereas in definitive erythroid
cells, the LCR exclusively contacts the adult-type b-globin genes
(b-major and b-minor), with the intervening embryonic globin
genes looped out (Palstra et al., 2003). Humans additionally
bear fetal stage-specific b-like globin (g-globin) genes that con-
tact the LCR and are transcribed from the beginning of fetal liver
erythropoiesis until birth when blood formation gradually shifts to
the bone marrow. Several transcription factors have been impli-
cated in loop formation at the b-globin locus, including Klf1,
GATA1, and its coregulators Ldb1 and FOG1 (Drissen et al.,
2004; Song et al., 2007; Vakoc et al., 2005). In previous work
we addressed whether any of these factors might be sufficient
for chromatin looping and whether looping is a causal event dur-
ing transcription initiation or merely a reflection of it (Deng et al.,
2012). Specifically, in immaturemurine erythroblasts in which the
b-globin promoter is not in contact with the LCR, tethering of
Ldb1 to the promoter via artificial zinc-finger (ZF) proteins estab-
lished an LCR-promoter loop similar to that observed in mature
erythroid cells and stimulated transcription (Deng et al., 2012).
The self-association (SA) domain of Ldb1 was sufficient for this
activity. These results demonstrated that forced juxtaposition
of an enhancer and promoter via chromatin looping can trigger
gene activation and identified a relatively small functional
domain of Ldb1 as a powerful mediator of such long-range inter-
actions. Therefore, it should be possible to activate any other
similarly regulated nearby gene by producing an interaction be-
tween it and the active LCR.
The molecular mechanisms mediating the developmental
switch in globin gene expression have been widely investigated.
A variety of nuclear complexes contribute to the silencing of theCell 158, 849–860, August 14, 2014 ª2014 Elsevier Inc. 849
embryonic and fetal globin genes in adult erythroid cells (San-
karan et al., 2010). Among these, arguably the most powerful
one is nucleated by Bcl11a (Sankaran et al., 2008, 2009), which
does not bind directly to promoters of the silenced human fetal
globin genes but seems to repress them via a mechanism
involving higher-order chromatin looping (Kiefer et al., 2011; Xu
et al., 2010). Hence, manipulating chromatin loops might be a
viable strategy to reverse the globin switch. The overarching in-
terest in these questions stems in part from the clinical impor-
tance of understanding hemoglobin switching. Patients affected
by sickle cell anemia and b-thalassemia experience a milder
course of the disease if they express elevated levels of fetal
hemoglobin in adulthood (Platt et al., 1994; Weatherall, 2001).
This observation in particular provided a major impetus for
studies over the last decades aimed at unraveling the mecha-
nisms by which the fetal globin genes are silenced with the ulti-
mate goal of reactivating their expression.
Here, we tested whether developmentally silenced embryonic
or fetal globin genes can be reactivated in adult erythroid cells by
juxtaposing them with the LCR and whether reactivation would
lead to a concomitant reduction in the adult-type globin genes.
We found that ZF mediated tethering of the SA domain of Ldb1
to the murine embryonic bh1-globin promoter activated tran-
scription in an adult-type erythroblast cell line and primary defin-
itive erythroid cells. This activity was abrogated in erythroid cells
from mice in which the LCR had been deleted, demonstrating
that embryonic globin gene activation was dependent on a
long-range LCR interaction. Primary human erythroid cells ex-
pressing the SA domain fused to a ZF moiety that targets the
g-globin promoters produced high quantities of g-globin
mRNA and protein in the vast majority of cells with an accompa-
nying reduction in adult-type globin expression. The reciprocal
alteration in fetal versus adult globin gene transcription was re-
flected in corresponding changes in contact frequencies with
the LCR.
Together, these studies demonstrate that stringent develop-
mental regulation of a gene can be overcome through the
manipulation of higher-order chromatin structure and that such
manipulations have the potential for therapeutic applications.
RESULTS
bh1-SA-Mediated Activation of an Embryonic Globin
Gene in Adult Erythroblasts
To examine the potential of forced gene looping in reprogram-
ming the b-globin locus, we began by using G1E erythroblasts.
G1E is a murine adult-type erythroid cell line that lacks the
erythroid transcription factor GATA1 (Weiss et al., 1997). As a
result, a productive interaction between the LCR and the adult
b-globin (b-major) promoter fails to form, and b-major mRNA
production is low (Vakoc et al., 2005). GATA1 deficiency is asso-
ciated with little to no Ldb1 recruitment to the promoter (Tripic
et al., 2009). Tethering Ldb1 or its SA domain to the b-major pro-
moter restored looping in a manner highly similar to that in
normal erythroid cells or G1E cells upon GATA1 restoration
(Deng et al., 2012). Here, we asked whether a similar approach
could be employed to achieve a distinct goal, which is to activate
the embryonic bh1-globin gene by tethering the Ldb1 SA domain850 Cell 158, 849–860, August 14, 2014 ª2014 Elsevier Inc.to its promoter to induce an interaction with the LCR (Figure 1A).
We designed custom ZF proteins and screened them for binding
to bh1-globin promoter sequences in vitro (see the Experimental
Procedures). Functional proteins were fused to the SA domain of
Ldb1 (bh1-SA) and introduced into G1E cells by retroviral infec-
tion. Infected cells were isolated by fluorescence-activated cell
sorting (FACS). Chromatin immunoprecipitation (ChIP) revealed
specific binding of bh1-SA to the bh1-globin promoter, but not
to the promoters of the other b-like globin genes (Figure 1B).
We observed a low but reproducible ChIP signal at the DNase
1 hypersensitive (HS) sites of the LCR, likely due to bh1-SA bind-
ing to endogenous Ldb1-containing complexes (Deng et al.,
2012). We next examined the effects of bh1-SA on bh1-globin
transcription by qRT-PCR. bh1-globin mRNA levels were
increased 368-fold over nonexpressing G1E cells or cells that
express a ZF protein targeting HS2 of the LCR (L-SA) (Figure 1C).
Restoration of GATA1 activity in G1E cells via expression of an
estradiol-inducible form of GATA1 (GATA1-ER) leads to erythroid
maturation and high-level induction of b-major transcription, as
well as low-level induction of bh1-globin (Figures 1C and 1D)
(Weiss et al., 1997; Welch et al., 2004). Hence, we investigated
whether bh1-SA expression was capable of raising bh1-globin
transcription in differentiating b-major producing erythroid cells.
Notably, bh1-SA induced bh1-globin levels 26-fold over control
cells, amounting to15%of total b-globin expression compared
to 0.5% in vector only containing cells (Figures 1C and 1D).
Tethering the SA domain to the LCR (L-SA in Figure 1) or b-major
promoter (Denget al., 2012; data not shown) did not activate bh1-
globin expression, confirming that the effects of bh1-SA are spe-
cific. Basal-level bh1-globin expression and bh1-SA-induced
bh1-globin transcription were higher in GATA1 replete cells
when compared to parental G1E cells, likely due to increased
LCR and promoter activities in the presence of GATA1 (Fig-
ure S1A available online). The substantial increase in bh1-globin
expression was associated with a trend toward lower b-major
expression (see also below) but without significant changes of
other erythroid genes, including those encoding a-globin and
Kit, indicating that the effects of bh1-SA are not simply a conse-
quence of differentiation induction (Figures 1D and S1B).
bh1-SA-Mediated Activation of Embryonic Globin Gene
Expression in Primary Adult Erythroblasts
To address whether bh1-SA activates expression of bh1-globin
in murine primary erythroid cells, we isolated immature definitive
(adult-type) erythroid progenitor cells from E13.5 wild-type fetal
livers by sorting for CD71 medium/low and Ter119 low popula-
tions (S0 cells) as described previously (Figure 2A) (Pop et al.,
2010). Cells were infected with a retroviral vector expressing
bh1-SA (infection rate >75%; data not shown) and expanded
for 48 hr, followed by measurements of transcript levels by RT-
qPCR (reverse transcription quantitative polymerase chain reac-
tion). bh1-SA activated bh1-globin transcription by almost 800-
fold compared to empty vector control (Figure 2B), exceeding
30% of total b-globin synthesis (Figure 2C). We noted that the
zinc finger alone also raised bh1-globin expression but only to
1/6 of the levels achieved by bh1-SA (Figures 2B and 2C).
Although the cause for this activity is unclear, we surmise that
zinc-finger binding might increase chromatin occupancy of
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Figure 1. Reactivation of the Silenced bh1-
Globin Gene in Adult Erythroid Cells by the
Tethered Ldb1 SA Domain
(A) Experimental strategy. In normal adult erythroid
cells, Ldb1 is part of a multiprotein complex at the
LCR and the b-major (bmaj) promoter and con-
tributes to LCR-b-major contacts. Zinc-finger-
mediated tethering of the SA domain of Ldb1 to the
bh1-globin promoter might juxtapose the bh1-
globin promoter to the LCR at the expense of the
b-major-LCR interaction.
(B) Anti-Flag ChIP in G1E cells expressing bh1-SA.
(C) mRNA levels of bh1-globin in G1E cells (left)
or G1E cells expressing activated GATA1-ER
(G1E+GATA1, right) transduced with empty vector
or vector expressing SA fused to an LCR-specific
zinc finger (L-SA) or bh1-specific zinc finger
(bh1-SA).
(D) (left) bh1 mRNA levels plotted as percentage of
total b-globin transcripts. (right) b-major expression
in G1E+GATA1 cells transduced with indicated
constructs. Expression is normalized to b-actin.
Error bars denote SD. n = 3.
See also Figure S1.
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Figure 2. Reactivation of the Silenced bh1-
Globin Gene in Primary Erythroid Progenitor
Cells by the Tethered Ldb1 SA Domain
(A) Surface phenotypic staging of E13.5 fetal liver
progenitor cells with Ter119 and CD71. Erythroid
maturation occurs as cells progress from S0 to S3
populations.
(B) Fold-activation of bh1-globin and b-major
mRNA levels relative to empty vector-infected cells
(MigR1).
(C) bh1-globin mRNA levels plotted as percentage
of totalb-globin transcripts fromS0cells transduced
with indicated constructs. Results were normalized
to GAPDH. Error bars denote SEM. n = 3.
See also Figure S2.nearby activators (Adams and Workman, 1995), which in turn
contribute to LCR recruitment.
We also examined the ability of bh1-SA to increase bh1-globin
expression in erythroblasts that are further differentiated (S1
populations) and obtained similar results (Figures S2A and
S2B). Importantly, b-major expression was slightly reduced in
both bh1-SA-expressing populations (Figures 2B and S2A),
consistent with the idea that bh1-SA recruits the LCR toward
the bh1-globin gene at the expense of the b-major gene. We
noted that bh1-SA impaired expression of a few erythroid spe-
cific genes, such as those encoding Band3, AHSP, and Alas2
(Figure S2C). Because these genes are in part regulated by pro-
moter proximal Ldb1-containing transcription factor complexes
(Tripic et al., 2009), bh1-SA likely influences their expression in a
dominant-negative fashion, especially when expressed very
highly (data not shown). However, in human erythroblasts, SA-
fusion proteins did not inhibit the orthologous genes (see below),
which might be due to species-specific effects and/or lower
expression levels. Nevertheless, these events do not substan-
tially impact overall erythroid maturation and a-globin gene
expression, indicating that bh1-globin activation is gene specific
and not the result of global differentiation induction.
Interestingly, the embryonic globin gene εy, which is located
closer to the LCR than the bh1 gene, was also activated to
some degree by bh1-SA expression in both S0 and S1 erythroid
precursor cells (Figure S2D). Since bh1-SA does not detectably
bind to the εy-globin gene promoter (Figure 1B), this suggests
that bringing the LCR closer into the vicinity of the εy-globin
gene increases its likelihood of expression.
In sum, recruitment of the Ldb1 SA domain to the bh1-globin
promoter is capable of substantially antagonizing the stringent852 Cell 158, 849–860, August 14, 2014 ª2014 Elsevier Inc.developmental silencing mechanisms
operational in definitive murine erythroid
cells. If a similar degree of reactivation of
fetal globin genes could be achieved in
adult human erythroid cells, this would be
highly therapeutically relevant (Platt, 2008).
bh1-SA Activation of bh1-Globin
Expression Is LCR Dependent
Based on our prior studies showing that
tethering of Ldb1 to the b-globin promotertriggers looping (Deng et al., 2012), the mechanism by which
bh1-SA activates gene expression most likely also involves pro-
moting proximity between the bh1-globin gene and the LCR. To
test this directly, we carried out chromosome conformation cap-
ture (3C) experiments in G1E cells expressing bh1-SA. However,
the relatively short genomic distance between the LCR and the
bh1-globin gene as well as the intervening εy-globin gene pro-
duced high basal-level 3C signals. Moreover, because the acti-
vation of bh1-globin expression ranged around 15% of total
b-globin synthesis, the signal-to-noise ratio of the 3C experi-
ments was not high enough to allow reliable detection of
changes in contact frequencies (data not shown). As an alterna-
tive approach, we carried out genetic experiments using
erythroid cells from mice lacking the LCR (DLCR) that contain
a transgenic human b-globin locus to support erythropoiesis
(Bender et al., 2000) (Figure 3A). If long-range LCR looping
underlies bh1-SA function, the LCR deletion should impair
bh1-SA activity. If, on the other hand, bh1-SA bypasses the
requirement for the LCR by functioning locally as a strong tran-
scriptional activator, its activity should be independent of the
LCR (Figures 1A and 3A).
bh1-SA was introduced into primary erythroid precursor cells
(S0 populations, gated as in Figure 2A) isolated from E13.5 fetal
livers derived from mice homozygous for the LCR deletion.
Although the loss of the LCR had no impact on basal level bh1-
globin transcription, it completely abrogated the induction of
bh1-globin expression seen in the wild-type mice (Figure 3B).
As expected, b-major expression in the DLCR cells was low
when compared with wild-type cells (Figure 3C). Transcription
of the a-globin gene that resides on a different chromosome
was unaffected by the LCR deletion (Figure 3D). Adventitious
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Figure 3. LCR Dependence of bh1-Globin
Induction by bh1-SA
(A) Experimental concept. Testing the activity of
bh1-SA in the absence of the LCR addresses
whether it functions locally at the bh1-globin pro-
moter or requires long-range LCR looping for
function.
(B–D) mRNA levels of indicated genes were
measured in S0 cells from wild-type or DLCR/
DLCR fetal liver cells expressing indicated con-
structs. Results were normalized to GAPDH. Error
bars denote SEM. n = 3.
See also Figure S3.activation of εy-globin expression was also abrogated in the
absence of the LCR (Figure S3A), consistent with a model in
which the LCR can form productive sporadic contacts with
nearby genes (Noordermeer et al., 2011). Similar results were
obtained using purified S1 cell populations (Figure S3B). In
conclusion, bh1-SA-mediated activation of bh1-globin transcrip-
tion requires the LCR and, by extension, is dependent on chro-
matin looping. 3C experiments carried out in human erythroid
cells further support the concept that zinc-finger SA fusion pro-
teins alter chromosome looping (see below).
Zinc Finger-SA-Mediated Activation of g-Globin
Transcription in Primary Adult Human Erythroid Cells
Wenext explored whether the strategy of forced chromatin loop-
ing could be employed to activate g-globin expression in adult
human erythroid cells (Figure 4A). To tether the Ldb1 SA domain
to the two highly similar Gg-globin and Ag-globin genes, we fused
it to a previously characterized artificial zinc-finger protein (called
GG1) that targets both promoters (Gra¨slund et al., 2005). The
fusion construct (GG1-SA) was HA-tagged and inserted up-
stream of an IRES-GFP cassette into a lentiviral vector contain-
ing the promoter of either theANK1 (ankyrin 1) orSPTB (spectrin)
genes to drive erythroid-specific expression (Wilber et al., 2010).
As a control, we used a construct containing just the g-globin
binding zinc-finger protein (GG1-Only). To assess DNA binding
specificity of GG1-SA in vivo, constructs were introduced into
the human hematopoietic cell line K562 and analyzed by anti-
HA ChIP. GG1-SA targeting was highly specific for the g-globin
promoters with little or no signal at the other globin promoters
(Figure 4B).
To determine whether GG1-SA augments g-globin expression
in primary adult human erythroid cells, we collected bone
marrow-derived human CD34+ hematopoietic progenitor cells
and differentiated them toward the erythroid lineage using a
previously described two-phase liquid culture system involving
an expansion and differentiation phase (Sankaran et al., 2008)
(Figure 4C). Cells were infected with lentivirus containing GG1Cell 158, 849–86constructs during the expansion phase
and sorted for GFP expression on day
10–12 of erythroid differentiation. GFP-
negative cells served as controls. Sorting
yielded pure populations of cells (Fig-
ure S4A) expressing comparable amounts
of GG1-SA or GG1-Only mRNA (Fig-ure S4B). Remarkably, GG1-SA-expressing cells produced
g-globin approximating 85% of total globin synthesis (defined
as g-globin plus b-globin) comparedwith25% inGFP-negative
cells (Figure 4D).
Basal levels of g-globin expression can rise upon exposure of
human erythroblasts to in vitro culture conditions (Fibach et al.,
1993; Sankaran et al., 2008). This is consistent with the human
fetal genesbeing silenced less stringently compared to themurine
embryonic globin genes (Sankaran et al., 2009). Nevertheless,
GG1-SA induced g-globin levels that rival or exceed those
achieved by pharmacological g-globin inducers (Atweh and Fa-
thallah, 2010; Bradner et al., 2010; Cao et al., 2004; Smith et al.,
2000) ordepletionofBcl11a (Sankaranet al., 2008;Xuetal., 2013).
We observed considerable variation in basal g-globin expres-
sion among donors ranging from <10% to 50% of total globin
synthesis (Figure S4C). As erythroid cells undergo maturation,
the ratio of fetal to adult hemoglobin declines. To ensure that
our observed increases in fetal globin production are not
confounded by variable rates of erythroid maturation due to
cell culture and donor variations and/or secondary to GG1-SA
expression, we normalized g-globin transcripts against a-globin
mRNA as an indicator of erythroid differentiation (Pope et al.,
2000). GG1-SA induced a2.5-fold increase in g-globin expres-
sion compared to GG1-Only and control (sorted GFP-negative
cells) populations (Figures 4E and S4D). Importantly, GG1-SA
expression resulted in a marked reduction in b-globin transcrip-
tion (13.5% versus control and 18.1%versusGG1-Only) (Figures
4E and S4D). Because the sum of g-globin and b-globin tran-
scripts remained similar vis-a`-vis a-globin mRNA levels, this
further supports the idea that GG1-SA functions via competition
for the LCR. Similar reciprocal changes in globin transcription
upon GG1-SA expression were observed when mRNA levels
were normalized to GAPDH (Figure S4E). Finally, GG1-SA
expression measurably increased the expression of the surface
marker CD235a (Figure S4F), suggesting that GG1-SA might
enhance erythroid maturation. This prompted us to assess a
panel of erythroid genes, which revealed a modest (%2-fold)0, August 14, 2014 ª2014 Elsevier Inc. 853
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Figure 4. Reactivation of the g-Globin Gene
in Primary Human Erythroid Cells by GG1-SA
(A) Experimental concept. Note the presence of
two fetal g-globin genes (Gg and Ag) in humans.
(B) Anti-HA ChIP analysis in K562 cells expressing
GG1-SA.
(C) Experimental outline.
(D) Percentage of g-globin and b-globin mRNA
levels as determined by qRT-PCR. GG1-SA ex-
pression was driven by the ankyrin promoter and
GG1-Only by the spectrin or ankyrin promoter.
Control cells are sorted GFP-negative cells.
(E) Absolute g-globin expression (left) and b-globin
(right) relative to a-globin expression in adult
erythroblasts. Error bars represent SEM. n = 15 for
GG1-SA, 11 for GG1-Only, and 26 for control.
Asterisks indicate statistically significant difference
from GG1-SA by t test.
See also Figure S4.increase of a subset of these (Figure S4G), suggesting that the
increased g- to b-globin ratio is not due to GG1-SA-mediated
alterations in erythroid differentiation. Together, these results
demonstrate that GG1-SA strongly induces the expression of
g-globin, with resulting loss in b-globin transcription.
GG1-SA-Mediated Induction of Fetal Hemoglobin in
Peripheral Blood-Derived Erythroid Precursor Cells
We next examined whether the GG1-SA-induced increase in
g-globin mRNA transcription is reflected in fetal hemoglobin
production at the protein level. CD34+ progenitor cells isolated
from peripheral blood were expanded, lentivirally infected, and
differentiated toward the erythroid lineage as described previ-
ously (Breda et al., 2012). Hemoglobin profiles were determined
by high-performance liquid chromatography (HPLC). GG1-SA
expression led to a dramatic increase in the percentage of HbF
compared to uninfected controls or GG1-Only (Figures 5A and
S5A; data not shown). Correspondingly, adult hemoglobin levels
(HbA and HbA2) declined markedly. These results match those
measuring g-globin and b-globin mRNA levels from these popu-
lations (data not shown). Similarly, we observed a dramatic rise
in absolute HbF production (as measured in micrograms of pro-
tein) with a concomitant reduction in HbA levels (Figure 5B). This
shift in hemoglobin production is likely an underestimate
because GG1-expressing cells were not enriched by cell sorting
in these experiments. Importantly, total hemoglobin produc-
tion remained unchanged between controls and GG1-SA con-
taining cells (Figure 5B), indicating that in these experiments
GG1-SA expression did not significantly affect overall erythroid
maturation.
Finally, we followed the effects of GG1-SA at two stages of
differentiation (day 4 and day 8) of peripheral blood-derived
erythroid cells by analyzing globin mRNA levels and cell surface
marker expression. At day 4 of erythroid differentiation, GG1-SA854 Cell 158, 849–860, August 14, 2014 ª2014 Elsevier Inc.strongly stimulated g-globin transcription
compared to controls with high levels
being sustained at day 8 (Figure S5B).
GG1-SA also attenuated b-globin tran-scription at both time points (Figure S5B). GG1-SA did not impair
erythroid differentiation but slightly promoted it as measured by
CD235a surface expression (Figure S5C), similar to the results
obtained with bone marrow-derived cells. Taken together, these
results demonstrate potent induction of HbF by GG1-SA at
distinct stages of erythroid differentiation and independent of
stem cell source.
Cellular Distribution of g-Globin Protein in Adult
Erythroid Cells Containing GG1-SA
Fetal hemoglobin (HbF) production is heterocellular in normal in-
dividuals in whom a small proportion of cells with high level of
HbF accounts for the overall low HbF levels (Boyer et al., 1975;
Wood et al., 1975). We examined the cellular distribution of
HbF in GG1-SA and GG1-Only-expressing bone marrow-
derived cultures by staining with an anti-HbF antibody, followed
by flow cytometry and immunofluorescence microscopy. GG1-
SA resulted in nearly pancellular HbF expression, whereas
GG1-Only triggered expression merely in a subset of cells (Fig-
ure 6), consistent with the mRNA analyses. This observation
further highlights the effectiveness of GG1-SA in stimulating fetal
globin synthesis.
GG1-SA Induces g-Globin Promoter-LCR Looping
Several lines of evidence support the model that zinc finger-SA
fusion proteins work via a looping mechanism, including their
reciprocal effects on embryonic/fetal and adult globin expres-
sion, the dependence on the LCR for activity, and prior 3C
studies, demonstrating the ability of Ldb1 and its SA domain to
trigger chromatin looping (Deng et al., 2012; Song et al., 2007).
To directly assess the effects of GG1-SA expression on chro-
matin contacts within the b-globin locus, we carried out 3C
experiments in adult erythroblasts. GG1-SA expression estab-
lished a strong interaction between the LCR and the g-globin
AB
Figure 5. GG1-SA Activates HbF Production
in Peripheral Blood-Derived Adult Erythroid
Cells
(A) Percent fetal hemoglobin (HbF, left), adult he-
moglobin (HbA, middle), and hemoglobin delta
(HbA2, right) in control peripheral blood-derived
erythroid cells versus GG1-SA containing cells as
measured by HPLC.
(B) Absolute level of HbF (left), HbA (middle), and total
hemoglobin (right) as determined by HPLC. Data
represent a total of 11 (A) and 10 (B) biological rep-
licates from a total of three different healthy donors.
Error bars represent SEM. Asterisks indicate statis-
tically significant difference from control by t test.
See also Figure S5.genes that is absent in control cells (Figure 7). Please note that
the primer pair (Gg) used for the two g-globin promoters does
not distinguish between these sequences, and the values repre-
sent the average normalized signals from both (Kiefer et al.,
2011). The contact frequencies of the intervening restriction frag-
ment (primer pair G/A) between the two g-globin genes are also
increased, albeit not as much as the g-genes themselves. Addi-
tionally, interactions between the LCR and the adult globin genes
(d- and b-globin) were diminished, consistent with GG1-SA
competitively reconfiguring looped contacts toward g-globin
promoter at the expense of the b-globin promoter. In light of
the variation among donor samples leading to sizeable error
bars, we plotted the individual 3C experiments showing essen-
tially the same results in all samples (Figure S6A). Finally, results
were robust toward different ways of normalizing the data (Fig-
ure S6B; data not shown). In sum, tethering the SA portion of
Ldb1 to the fetal globin promoters promotes their juxtaposition,
with the LCR leading to transcription activation, with accompa-
nying reduction in the expression of adult globin genes.
DISCUSSION
Here, we reprogrammed a developmentally regulated gene
locus by manipulating its chromatin organization. In adult
erythroid cells, redirecting the LCR to the silenced embryonic
or fetal b-type globin promoters by targeted tethering of the
Ldb1 SA domain strongly activated transcription at the expense
of the adult b-globin genes, thus at least partially reversing the
developmental gene switch (Figure 7B). Our findings support
that chromatin looping plays an essential role in controlling
globin switching and suggest a possible strategy for the treat-
ment of those hemoglobinopathies that would benefit from the
activation of alternative b-like globin genes. More broadly, they
exemplify controlled manipulation of chromatin folding in theCell 158, 849–8nucleus as a novel and powerful strategy
to modulate, positively or negatively, the
transcription of designated genes.
Central to the mechanism of globin gene
switching is the exclusive interaction be-
tween the LCR and globin gene promoters
at distinct developmental stages (Carter
et al., 2002; Palstra et al., 2008; Tolhuiset al., 2002). In adult-typemurine erythroid cells, Ldb1 is required
for the juxtaposition between the LCR and the adult b-major
globin gene (Deng et al., 2012; Song et al., 2007). The present re-
sults indicate that the Ldb1 SA domain is also capable of forging
a chromatin interaction between the LCR and globin genes that
represents earlier stages of development, leading to marked in-
creases in transcription.
Several lines of evidence strongly support loop formation as
the underlying mechanism of transcriptional activation. First,
deletion of the LCR essentially abrogated the effects of the teth-
ered Ldb1 SA domain, indicating that it does not substitute for
the LCR by simply enhancing promoter activity but instead re-
quires long-range LCR action. Second, increases in embryonic
or fetal globin gene expression were accompanied by a recip-
rocal decrease in adult b-globin expression, consistent with
competition for long-range LCR activity. Third, 3C experiments
revealed that GG1-SA expression strongly stimulated g-globin
promoter-LCR interactions with a concomitant decrease in
b-globin-LCR contacts. Finally, previous 3C experiments
demonstrated the sufficiency of tethered Ldb1 for full reconstitu-
tion of an LCR-b-globin promoter loop in immature adult
erythroid cells in which the globin locus is otherwise unlooped
(Deng et al., 2012). Therefore, in aggregate these data strongly
support that Ldb1 SA-induced transcriptional activation is a
functional consequence of its impact on the higher-order chro-
matin organization within the b-globin locus.
Prior studies involving transgenic mice suggested that
genomic proximity to the LCR correlates with the ability to
compete for LCR activity, presumably because closer genes
have a higher probability of forging a productive interaction
(Bauchwitz and Costantini, 2000; Hanscombe et al., 1991; Peter-
son and Stamatoyannopoulos, 1993; Tanimoto et al., 1999). We
observed that bh1-SA not only activated bh1-globin expression
but also, to some degree, activated the expression of εy-globin,60, August 14, 2014 ª2014 Elsevier Inc. 855
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Figure 6. Cellular Distribution of g-Globin Protein in Primary Human Erythroid Cells
Erythroid cells derived from bone marrow CD34+ populations expressing indicated constructs stained with an anti-HbF antibody (red) and DAPI (blue) and
analyzed by flow cytometry (upper). Cells analyzed by anti-HbF immunofluorescence microscopy (lower).which resides closer to the LCR than to bh1-globin. Similar to
bh1-globin, εy-globin upregulation was dependent on the LCR.
Therefore, the newly imposed spatial constraint of the LCR
also increases the likelihood for interaction with a nearby gene.
This lends further support to the idea that spatial proximity is a
key determinant of enhancer activity.
Because numerous protein complexes orchestrate the devel-
opmental switch in b-globin gene expression (Sankaran et al.,
2010), it came as a surprise that a single molecule could exert
such strong activating effects on the embryonic or fetal globin
genes in adult erythroid cells. This indicates that direct recruit-
ment of the active LCR to the g-globin genes can effectively
override its developmental repression. As a corollary, it is plau-
sible that regulation of chromatin looping might also underlie
the function of factors normally involved in globin gene switch-
ing. Indeed, Bcl11a, a potent silencing factor of the g-globin
genes in human cells, does not detectably bind to the g-globin
gene promoters but appears to regulate the looped configuration
of the locus (Xu et al., 2010). Future studies analyzing the
effects of forced LCR-g-globin looping on the various postulated
g-globin repression mechanisms are expected to provide addi-
tional insights into the control of normal developmental globin
switching.
Tethering the SA domain did not activate murine embryonic
genes to the same level as the human fetal genes. This is consis-
tent with a more stringent developmental repression within the
murine environment (Sankaran et al., 2009). Exposure of devel-
oping human erythroid cells to in vitro culture conditions variably
elevates basal fetal globin gene expression, suggesting that the
human g-globin genes are in a poised and therefore more
responsive state when compared to the murine embryonic856 Cell 158, 849–860, August 14, 2014 ª2014 Elsevier Inc.genes. (Fibach et al., 1993). Hence GG1-SA might act in an envi-
ronment that is more favorable for further activation. It is also
possible that the chromatin state at the fetal globin genes facili-
tates more efficient access of GG1-SA to its target site. How-
ever, even under the most restrictive conditions, as are found
in murine cells, the silent bh1-gene promoter remains accessible
to bh1-SA and allows for activation of bh1-globin expression up
to 30% of total b-globin synthesis. In fact, such levels, if
achieved at the fetal globin genes in human sickle cell anemia
patients would be sufficient to ameliorate the clinical course of
their disease (see also below) (Noguchi et al., 1988; Platt et al.,
1991). If desired, means to further increase the efficiency of em-
bryonic or fetal globin transcription induction could be
conceived. Improvements in ZF design or the use of multiple
ZF proteins could potentially enhance the specificity and effi-
ciency to raise the competitiveness of the targeted gene for
enhancer activity. Alternative approaches for recruiting the SA
domain, such as through TALEs or catalytically inactive
CRISPR-Cas9 systems, could also be tested (Perez-Pinera
et al., 2013; Sun et al., 2012).
Currently, numerous strategies involving molecular genetic
tools are being pursued with the goal to ameliorate sickle cell
anemia. These include the transgenic expression of g-globin
or antisickling forms of b-globin and genome editing to repair
the sickle cell mutation or to diminish the expression of Bcl11a
(Chandrakasan and Malik, 2014; Bauer et al., 2013; Hardison
and Blobel, 2013). These approaches, including the one
presented here have specific strengths but also weaknesses
that must be considered prior to their potential use in
human patients. Several insights from our studies are relevant
when considering a forced looping approach for therapeutic
AB
Figure 7. GG1-SA Induces g-Globin Pro-
moter-LCR Looping
(A) 3C assay measuring locus-wide crosslinking
frequencies in differentiated human erythroid cells
expressing GG1-SA (red) or GFP-negative control
cells (blue). The EcoRI fragments containing HSs of
the LCR (black bar) was used as the anchor region.
Its crosslinking frequency with other indicated
EcoRI fragments (names on the top of the graph)
were assessed. The human b-globin genes are
depicted on the bottom of the graph, with chro-
mosomal position coordinates. The EcoRI diges-
tion sites are depicted as yellow triangles. Results
were obtained using primary bone marrow-derived
erythroid cells from three independent donors. 3C
values were normalized to tubulin, and the highest
3C value from the Gg-containing fragment (Gg
primer) in the GG1-SA sample of each independent
experiment was set as one. Error bars indicate
SEM. n = 3.
(B) Model of controlling chromatin looping to
reprogram the b-globin locus.
See also Figure S6.intervention. First, increases in fetal g-globin expression were
accompanied by reduced adult b-globin expression. This
agrees with the notion that the LCR is incapable of interacting
with multiple globin promoters at once but instead contacts
either the fetal genes or the adult genes (Enver et al., 1990; Wij-
gerde et al., 1995). The reduction in adult b-globin expression
might be an added therapeutic benefit because diminished syn-
thesis of defective b-globin chains, as occurs in sickle cell
anemia, would further improve the ratio of g-globin chains avail-
able to pair with the a-globin chains. Second, in normal adults,
total fetal hemoglobin synthesis ranges below 3% but is
concentrated in a small fraction of cells with high fetal hemoglo-
bin expression (F-cells). However, GG1-SA expression raised
fetal globin expression in the vast majority of transduced cells.
Therefore, it is expected that in a therapeutic setting fewer
dysfunctional erythroid cells would remain to contribute to dis-
ease. Finally, marked effects in fetal globin reactivation were
achieved with relatively low levels of GG1-SA transgene expres-
sion (<1% of globin genes), which may be a more easily achiev-
able and sustainable compared to what would be required if
expressing a g-globin transgene.
In summary, we have shown that forced long-range chromatin
interactions can be used to reactivate a developmentally
silenced gene. When employed at a complex gene locus atCell 158, 849–86which promoters compete for enhancer
activity, this strategy can lead to a recip-
rocal reduction in the expression of alter-
nate genes. Therefore, manipulation of
chromatin looping can in principle be
applied for gene activation or repression
at any gene that is controlled by a looped
distal enhancer. Refinements in targeted
tethering technologies and the explora-
tion of additional nuclear factors involved
in chromatin looping are expected to in-crease the appeal of this technology for a wider range of
applications.
EXPERIMENTAL PROCEDURES
Artificial Zinc-Finger Design
Custom ZF proteins each containing six tandem Cys2-His2 domains were de-
signed to target 18–19 base pairs at the bh1-globin promoter. ZFs were
assembled from two-finger units and screened for DNA binding by ELISA
assay in vitro as described previously (Bartsevich et al., 2003). Chosen target
sequences were within the DNase I hypersensitive region to facilitate access
but to avoid interference with known transcription factor binding sites. Five
ZFs were FLAG tagged and screened by anti-FLAG ChIP for in vivo binding
to the bh1 promoter in G1E cells. Two of these produced sufficiently high
ChIP signals with the desired specificity. The better of the two with the target
sequence AAGGGGAGCAAGGTCCAG was used for experiments in this
report. The lesser one also activated bh1 expression albeit to a lower degree
(data not shown). The ZFs targeting HS2 of the mouse LCR and the human
g-globin promoters have been described previously (Deng et al., 2012; Gra¨s-
lund et al., 2005).
Constructs
The bh1-globin zinc-finger cDNA was cloned into MigR1 retroviral vector with
three Flag tags and a nuclear localization signal (NLS) at its N terminus. The SA
domain containing amino acids 1–200 of Ldb1 was inserted C-terminal to the
ZF. The lentiviral vectors pCL20 expressing the GG1 from the spectrin or
ankyrin promoter were gifts from Andrew Wilber (Wilber et al., 2010). The SA0, August 14, 2014 ª2014 Elsevier Inc. 857
domain was attached C-terminal to GG1 tagged with HA. GG1-Only contains
GG1 with an attached HA-tag.
Cell Culture
G1E cells were cultured as described previously (Weiss et al., 1997). G1E cells
containing GATA1-ERwere treated with 100 nM estradiol for indicated periods
of time (denoted as G1E+GATA1). K562 cells were grown in IMDM medium
supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin.
Mouse Primary Erythroblasts
Fetal liver erythroid cells were isolated from strain-matched E13.5 wild-type or
DLCR/DLCR embryos (129 strain) (Bender et al., 2000), according to protocol
2012-7-660. Single-cell suspensions were reacted with PE-conjugated anti-
CD71 and APC-conjugated anti-Ter119 antibodies and sorted by FACS. S0
and S1 populations (Figure 2A) were infected with retrovirus and cultured for
43–48 hr in medium containing IMDM with 15% fetal bovine serum, 1% peni-
cillin-streptomycin, 1% glutamine, 10 ng/ml mIL3, 20 ng/ml mIL6, 50 ng/ml
mSCF, 10 ng/ml mFLT3L, 0.5 U/ml erythropoietin (Amgen), and 1 mM dexa-
methasone (Sigma).
Two-Phase Differentiation of Bone Marrow-Derived Human CD34+
Cells
Human CD34+ cells were obtained from deidentified healthy bone marrow
donors after informed consent by the University of Pennsylvania Stem Cell
Core. Cells were expanded in StemSpan SFEM medium with 13 StemSpan
CC100 cytokine cocktail (STEMCELL Technologies) and 1% penicillin-strep-
tomycin, followed by differentiation in medium consisting of SFEM medium,
1 U/ml erythropoietin, 5 ng/ml IL3, 20 ng/ml SCF, 1 mM estradiol, and 2 mM
dexamethasone. On day 10–12 of differentiation, GFP+ cells were sorted on
a MoFlo XDP (Beckman Coulter) or an Ariall (BD Biosciences) cell sorter.
Cell purity was confirmed by postsort flow cytometry.
Two-Phase Differentiation of Peripheral Blood-Derived Human
CD34+ Cells
Peripheral blood was obtained from healthy donors after obtaining written
consent, in accordance with protocol 05070077971 from the Weill Cornell
Medical College Institutional Review Board. The mononuclear fraction from
a Ficoll-Hypaque density gradient was enriched for CD34+ cells by immuno-
magnetic separation using the CD34 Microbeads Kit (Miltenyi Biotec). Expan-
sion and differentiation were achieved using a protocol as described
previously (Breda et al., 2012). Briefly, cells were expanded in StemSpan
SFEMmedium, 13 StemSpan CC100 cytokine cocktail, 2 U/ml Erythropoietin,
1 mM dexamethasone (Sigma), and 1% penicillin-streptomycin. Differentiation
was induced in StemSpan SFEMmedium, 10 ng/ml SCF, 10 mM b-mercaptoe-
thanol, 10 U/ml erythropoietin, and 1% penicillin-streptomycin.
Viral Infections
Retroviral infections of G1E cells have been described (Tripic et al., 2009). For
primary fetal liver cells, spin-infection conditions were modified to 2,000 rpm
at room temperature for 1 hr with appropriate cytokines added, and cells were
switched to fresh medium immediately after infection. Lentivirus was concen-
tratedusingPeg-itVirusPrecipitationSolution (SystemBiosciences) orultracen-
trifugation. Primary human cells were infected on two consecutive days starting
at the second or third day of the expansion phase with freshly prepared virus.
Cells were spin-infected at 2,250 rpmat room temperature for 1.5 hrwith appro-
priate cytokines. K562 cells were spin-infected once using the same conditions.
Chromatin Immunoprecipitation
Anti-HA (clone 12CA5) and anti-Flag (clone M2, F3165, Sigma) ChIP was per-
formed as described (Tripic et al., 2009) using primers listed in Table S1.
qRT-PCR
RNA from 105–106 cells was extracted with Trizol (Invitrogen). Reverse-tran-
scription reactions were performed with random hexamers using Superscript
II (Invitrogen) or iScript (Bio-Rad). cDNA samples were quantified by
SybrGreen qPCR. The primers for human b-globin amplify both b-globin and
d-globin cDNA with d-globin contributing less than 6% of the total.858 Cell 158, 849–860, August 14, 2014 ª2014 Elsevier Inc.Immunostaining
Human primary cells were stained with an APC-conjugated fetal hemoglobin
antibody (Invitrogen, MHFH05) using the BD Cytofix/Cytoperm Kit (BD Biosci-
ences), per the manufacturer’s protocol. Surface staining was performed with
PE-labeled antiCD71 and APC-labeled antiCD235a (BD Biosciences).
HPLC Analyses
Hemolysis of cells was achieved in ice water for 30 min and two cycles of
freeze thawing. Hemoglobin content and quality were analyzed by HPLC as
described previously (Ou and Rognerud, 1993), using a PolyCAT A column
(cat # 3.54CT0315; 3 m, 1500 A˚ PolyLC) on a System Gold 126 Solvent Module
instrument (Beckman Coulter). Hemoglobins were measured at a wavelength
of 415 nm and compared to hemoglobin standards with known concentration
(Analytical Control System).
Chromosome Conformation Capture
3C assays were performed as described (Hage`ge et al., 2007) with the
following modifications. Cells (2 3 106) were crosslinked with 1% formalde-
hyde at room temperature for 10min, followed by glycine quenching, cell lysis,
EcoRI digestion, and T4 ligation. 3C ligation products were quantified in tripli-
cates by quantitative SYBR Green real-time PCR as described previously
(Kiefer et al., 2011). The 3C signals were normalized to template standards
generated from a locus-specific BAC and to 3C signals from the tubulin locus.
To eliminate variability between donor samples, interaction frequencies be-
tween the anchor fragment and the fragment encompassing the Gg-globin
gene (Figure 7A) or the b-globin (Figure S6B) from the GG1-SA sample of
each donor were set to one. Primer sequences are listed in Hou et al. (2010),
Kiefer et al. (2011), and Table S1.
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